Back to results
US 2019/0153448 A1Published application
Inhibitory rna-based therapeutics targeting anln for cancer treatment
AssigneeBoard of Regents, The University of Texas System
InventorsHao ZHU, Shuyuan ZHANG
Life of this patent
Estimating the term…
Abstract
Embodiments of the present disclosure include compositions and methods related to certain siRNA compositions for the treatment of cancer. In specific embodiments, siRNAs are employed for treatment of cancer, including at least liver cancer. Therapeutic methods, compositions, and kits are encompassed in the disclosure.
Claims21
An interfering RNA that targets an anillin actin binding protein mRNA.
(canceled)
Dependencies are inferred from the claim text.